期刊文献+

针对Her-2基因的小分子干扰RNA对卵巢上皮性癌细胞生物学行为影响的研究 被引量:4

Effects of small interfering RNA specific for Her-2 gene on biological behavior of ovarian carcinoma cell
原文传递
导出
摘要 目的通过小分子干扰RNA(siRNA)对Her-2基因表达的影响,探讨其对卵巢上皮性癌(卵巢癌)细胞生物学行为的影响。方法针对Her-2基因的siRNA质粒和阴性对照质粒在脂质体介导下转染到包装病毒细胞株PT67中,嘌呤霉素筛选细胞克隆,收集其上清液并感染SKOV3细胞,经过嘌呤霉素筛选得到稳定转染的细胞株SKOV3/siRNA、SKOV3/siRNA-negative,并通过RT-PCR和免疫组化方法鉴定Her-2基因表达的抑制效果。用四甲基偶氮唑蓝法检测细胞增殖并绘制生长曲线,通过流式细胞仪检测细胞周期、细胞凋亡,并将稳定转染的细胞株接种到裸鼠皮下检测成瘤情况。结果(1)SKOV3/siRNA细胞Her-2基因的表达明显减弱。(2)SKOV3/siRNA细胞的G0/G1期细胞占68·6%,S期细胞占15·1%,SKOV3/siRNA-negative细胞的G0/G1期占55·8%,S期占23·3%。(3)SKOV3/siRNA细胞的早期凋亡率为(10·500±0·250)%,而SKOV3/siRNA-negative细胞为(0·340±0·010)%,两者比较,差异有统计学意义(P<0·01)。(4)与SKOV3/siRNA-negative细胞比较,SKOV3/siRNA细胞的生长速度减慢(P<0·05),接种于裸鼠皮下的肿瘤生长速度明显减慢(P<0·01)。结论siRNA可以有效抑制Her-2基因的表达,抑制卵巢癌细胞的生物学行为。 Objective To explore the effects of small interfering RNA (siRNA) specific for Her-2 gene on biological behavior of ovarian carcinoma cell. Methods Her-2 siRNA recombinant plasmid and negative control plasmid were transfected into packing cell line PT67 by liposome, and PT67 was selected by puromycin later. SKOV3 was infected by the virus supernatant of stably transfected PT67 cell lines, and the stably transfected SKOV3 cell lines (SKOV3/siRNA, SKOV3/siRNA-negative) established by selection with puromycin were investigated in terms of the reduction levels of Her-2 mRNA and p185 by RT-PCR and immunohistochemistry. Cell proliferation was assayed with methyl thiazolyl tetrazolium, and cell cycle distribution and cell apoptosis were assayed with flow cytometry. The tumor growth of the null mice was analyzed after injection of SKOV3/siRNA and SKOV3/siRNA-negative into the skin. Results ( 1 ) The stable SKOV3 cell lines with a persistent silence of Her-2 gene were established. (2) The percentages of SKOV3/siRNA in G0/G1 phase and S phase were 68.6%, 15.1% respectively; while the percentages of SKOV3/siRNA-negative in G0/G1 phase and S phase were 55.8%, 23.3% . ( 3 ) The percentage of SKOV3/siRNA in early apoptosis was (10. 500 ± 0. 250 )%, while the percentage of SKOV3/siRNA- negative was (0.340 ± 0.010)% (P 〈 0.01 ) . (4) Compared with SKOV3/siRNA-negative, the proliferation of SKOV3/siRNA was delayed obviously ( P 〈 0. 05 ), and the growth of the corresponding implanted tumor slowed down significantly (P 〈 0.01 ). Conclusion siRNA can inhibit the expression of Her-2 gene effectively, which restrains the biological behavior of ovarian carcinoma cell.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2006年第12期830-833,共4页 Chinese Journal of Obstetrics and Gynecology
基金 安徽省自然科学基金资助项目(050430715) 安徽省高等学校自然科学研究项目(2005KJ347ZC)
关键词 基因 ERBB-2 RNA 小分子干扰 卵巢肿瘤 Genes, erbB-2 RNA, small interfering Ovarian neoplasms
  • 相关文献

参考文献12

  • 1Hogdall EV,Christensen L,Kjaer SK,et al.Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma:from the Danish MALOVA Ovarian Cancer Study.Cancer,2003,98:66-73.
  • 2Skirnisdottir I,Sorbe B,Seidal T.The growth factor receptors HER-2/neu and EGFR,their relationship,and their effects on the prognosis in early stage (FIGO Ⅰ-Ⅱ) epithelial ovarian carcinoma.Int J Gynecol Cancer,2001,11:119-129.
  • 3Ochsenbein AF,Sierro S,Odermatt B,et al.Roles of tumour localization,second signals and cross priming in cytotoxic T-cell induction.Nature,2001,411:1058-1064.
  • 4Camilleri-Broet S,Hardy-Bessard AC,Le Tourneau A,et al.HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma:a multicenter study of the GINECO group.Ann Oncol,2004,15:104-112.
  • 5Filip E,Campo JM,Rubio D,et al.Overexpression of c-erbB-2 in epithelial ovarian cancer.Prognostic value and relationship with response to chemotherapy.Cancer,1995,75:2147-2152.
  • 6Brodowicz T,Wiltschke C,Budinsky AC,et al.Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitro.Int J Cancer,1997,73:875-879.
  • 7Xu FJ,Stack S,Boyer C,et al.Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2):increased invasiveness may contribute to poor prognosis.Clin Cancer Res,1997,3:1629-1634.
  • 8Brummelkamp TR,Bernards R,Agami R.A system for stable expression of short interfering RNAs in mammalian cells.Science,2002,296:550-553.
  • 9Chiu YL,Ali A,Chu CY,et al.Visualizing a correlation between siRNA localization,cellular uptake,and RNAi in living cells.Chem Biol,2004,11:1165-1175.
  • 10Peebles D,Gregory LG,David A,et al.Widespread and efficient marker gene expression in the airway epithelia of fetal sheep after minimally invasive tracheal application of recombinant adenovirus in utero.Gene Ther,2004,11:70-78.

同被引文献36

  • 1吴家璐,李龙芸.荧光原位杂交技术对胸腔积液间期细胞染色体数目异常的研究[J].癌症进展,2005,3(5):467-470. 被引量:13
  • 2凌斌.子宫颈癌诊断与治疗的新进展[J].中国实用妇科与产科杂志,2007,23(1):23-25. 被引量:67
  • 3Souglakos J, Vamvakas L, Apostolaki S et al. Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/ neu status. Breast Cancer Res, 2006, 8 (14) :R36
  • 4Im SA, Lee KE, Nam E et al. Potential prognostic significance of p185 ( HER2 ) overexpression with loss of PTEN expression in gastric carcinomas. Tumori, 2005, 16:513
  • 5Narisawa - Satio W, Handa K, Yugawa T et al. HPV16 E6 - mediated stabilization of ErbB2 in neoplastic transformation of human cervical keratinocytes. Oncogene, 2007, 26:2988
  • 6Niibe Y, Nakano T, Ohno T et al. Prognostic significance of c -erbB -2/ HER -2 expression in advanced uterine cervical carcinoma with para - aorticlymph node metastasis treated with radiation therapy. Gynecol Cancer, 2003, 13:849
  • 7Heselmeyer - Haddad K, Janz V, Castle PE et al. Detection of genomic amplification of the human telomcrase genc (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. Am J Pathol, 2003, 163 (4): 1405
  • 8Olaharski A J, Sotelo R, Solorza - Luna G et al. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis, 2006, 27 (2): 337
  • 9Heselmeyer- Haddad K, Sommerfeld K, White NM et al. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer. Am J Pathol, 2005, 166 ( 4 ) : 1229
  • 10Carreras R, Alameda F, Mancebo G et al. A study of Ki -67, c -erbB2 and cyclin D - 1 expression in CIN - Ⅰ, CIN - Ⅲ and squamous cell carcinoma of the cervix. Histol Histopathol, 2007, 22 (6) : 587

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部